Pharma Nachrichten

Zeit	Aktuelle Nachrichten Sprache: Alle DE EN	Leser	Medien
21:47	Novartis und Unnatural Products kooperieren bei Peptid-Therapeutika	3	cash
21:42	Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults	112	Business Wire	Olanzapine long-acting injectable suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation 1 If approved, TEV-'749 could help... ► Artikel lesen
21:29	Stocks in Play: Doseology Sciences Inc	1	Baystreet.ca
21:21	GROOVE BOTANICALS INC. - 10-Q, Quarterly Report	2	SEC Filings
21:06	FDA accepts Teva's application for monthly olanzapine injection	2	Investing.com
21:06	Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)	2	Benzinga.com
21:06	Doseology Sciences Inc (2): Doseology Sciences appoints Latowsky as chairman	2	Stockwatch
20:58	Teva Pharmaceutical Industries Ltd: U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults	220	GlobeNewswire (Europe)	Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address... ► Artikel lesen
20:58	FDA nimmt Zulassungsantrag von Teva Pharm für monatliche Olanzapin-Injektion an	2	Investing.com Deutsch
20:39	AbbVie Inc. - 10-K, Annual Report	6	SEC Filings
20:26	Ionis scraps early candidate for Alzheimer's in people with Down syndrome	1	FierceBiotech
20:18	Thomas Kean Jr makes strategic moves in Abbott Laboratories and General Motors	5	Investing.com
20:15	Dividendenbekanntmachungen (20.02.2026)	2.323	wallstreetONLINE (Dividenden)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASX LIMITED AU000000ASX7 1,018 AUD 0,6103 EUR ATMUS FILTRATION TECHNOLOGIES INC US04956D1072 0,055 USD 0,0467 EUR AUDIOCODES LTD IL0010829658 0... ► Artikel lesen
20:06	Analyst Expectations For Charles River's Future	3	Benzinga.com
20:06	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2026	228	Xetra Newsboard	The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2026ISIN NameCA1926671035 COLABOR... ► Artikel lesen
20:01	Forget Ozempic: This High-Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins	20	The Motley Fool
19:36	Vistin Pharma ASA: Mandatory notification of trade	1	GlobeNewswire (USA)
19:30	JEFFERIES stuft NOVARTIS AG auf 'Hold'	367	dpa-AFX-Analyser	NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Novartis auf "Hold" mit einem Kursziel von 110 Franken belassen. Nach den Zahlen zum vierten Quartal halte er die Aktie... ► Artikel lesen
19:18	Happy Belly Food Group Inc: Happy Belly's Heal to open Oakville store Feb. 21	1	Stockwatch
18:57	Bayer Korrektur: Kurs rutscht unter wichtige Chartmarke	569	börsennews.de	Die anfängliche Euphorie über einen Milliardenvergleich im US-Rechtsstreit ist bei den Aktionären von Bayer rasch verflogen. Das Papier verzeichnete zum Wochenausklang deutliche Verluste und durchbrach... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Sprache: Alle DE EN

Leser

Medien

21:47

Novartis und Unnatural Products kooperieren bei Peptid-Therapeutika

cash

21:42

Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

112

Business Wire

Olanzapine long-acting injectable suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation 1 If approved, TEV-'749 could help...
► Artikel lesen